Awareness of Physicians and Clinical Pharmacists About ACC/AHA Guidelines for Dyslipidemia Management: A Cross-Sectional Study.

American College of Cardiology/American Heart Association atherosclerotic cardiovascular disease cardiovascular diseases clinical pharmacists dyslipidemia guidelines physicians

Journal

Journal of pharmacy & bioallied sciences
ISSN: 0976-4879
Titre abrégé: J Pharm Bioallied Sci
Pays: India
ID NLM: 101537209

Informations de publication

Date de publication:
Historique:
entrez: 1 6 2019
pubmed: 1 6 2019
medline: 1 6 2019
Statut: ppublish

Résumé

Cardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality worldwide. Although genetics could contribute to the incidence of CVD, they are mostly acquired conditions. Management of precipitating factors such as hyperlipidemia can prevent CVD. Therefore, clinical guidelines have been used as a tool to improve patient outcomes and minimize practice variation. The objective of this study was to assess health-care providers' (physicians and clinical pharmacists) awareness about the latest edition of the American College of Cardiology/American Heart Association (ACC/AHA) guidelines of dyslipidemia management. To meet the study objective, a self-administered questionnaire was designed based on the recommendations of the latest edition of the ACC/AHA guidelines for dyslipidemia management. After validation, the questionnaire was distributed to physicians and clinical pharmacists in Al-Ahsa province of Saudi Arabia. Validation of the questionnaire was carried on 10 participants (Cronbach's alpha = 0.816). Seventy-seven participants completed the questionnaire (acceptance rate = 51.33%). The majority of participants knew about the release of the ACC/AHA 2013 guidelines for dyslipidemia (77% of the physicians and 48% of the clinical pharmacist). Inadequate knowledge of the major changes in the dyslipidemia management was observed in both study groups with no significant difference between them (the median score for physicians and pharmacists was 4 out of 10 with a range of 1-9, Z = -0.15, Inadequate level of knowledge about practice-changing recommendations of the recent ACC/AHA guidelines for dyslipidemia management was observed among the study participants. This level of knowledge could result in clinical malpractice and worsen management outcomes. Thus, efforts should be in place to raise awareness about the evidence-based management of dyslipidemia and monitor compliance to guidelines and their implementation outcomes.

Identifiants

pubmed: 31148896
doi: 10.4103/jpbs.JPBS_59_18
pii: JPBS-11-181
pmc: PMC6537640
doi:

Types de publication

Journal Article

Langues

eng

Pagination

181-186

Références

Fam Pract. 2001 Aug;18(4):359-63
pubmed: 11477041
JAMA. 2002 Oct 16;288(15):1909-14
pubmed: 12377092
Circulation. 2005 Feb 1;111(4):499-510
pubmed: 15687140
Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):521-9
pubmed: 16319540
J Am Board Fam Med. 2006 Jan-Feb;19(1):46-53
pubmed: 16492005
J Vasc Surg. 2006 Jun;43(6):1205-10
pubmed: 16765240
Saudi Med J. 2008 Feb;29(2):282-7
pubmed: 18246242
Atherosclerosis. 2010 Dec;213(2):598-603
pubmed: 20947087
Eur J Prev Cardiol. 2012 Jun;19(3):541-50
pubmed: 21502280
Int J Clin Pharm. 2011 Apr;33(2):229-36
pubmed: 21744191
Isr Med Assoc J. 2011 Nov;13(11):657-62
pubmed: 22279697
Pharmacotherapy. 2012 Mar;32(3):222-33
pubmed: 22392455
Prim Care. 2013 Mar;40(1):195-211
pubmed: 23402469
BMC Fam Pract. 2013 Apr 04;14:47
pubmed: 23557543
JAMA Intern Med. 2013 Sep 23;173(17):1581-3
pubmed: 23897435
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934
pubmed: 24239923
Ann Epidemiol. 2014 Nov;24(11):801-8
pubmed: 25281531
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Can J Cardiol. 2016 Nov;32(11):1263-1282
pubmed: 27712954
Int J Gen Med. 2018 Jul 18;11:313-322
pubmed: 30050317
Arch Intern Med. 1998 Jun 8;158(11):1238-44
pubmed: 9625403

Auteurs

Mohammad Fathullah Zaitoun (MF)

Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al Hofuf, Kingdom of Saudi Arabia.

Mais Hasan Iflaifel (MH)

Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al Hofuf, Kingdom of Saudi Arabia.

Loloah Abdullah Almulhim (LA)

Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia.

Mohammed Ali Al-Ghamdi (MA)

Prince Sultan Cardiac Center, Al-Ahsa, Kingdom of Saudi Arabia.

Yasir Ahmed Ibrahim (YA)

Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al Hofuf, Kingdom of Saudi Arabia.

Classifications MeSH